Nortis Inc. Our mission is to develop the 21st century gold standard for preclinical testing, accelerating the discovery of new therapies while reducing the use of animals. While OoCs are not electrical circuits, the term chip derives from the silicon-based platform on which the technology was conceived.

OoCs, also known as microphysiological systems (MPS), closely mimic human physiology, enabling more accurate research beyond animal-based models. Unlike traditional in vitro research, where cells or tissue are removed from their native environments, Nortis' groundbreaking ParVivo™ System offers Pre-Seeded Chips with engineered functional human tissues. Our plug-and-play paradigm eliminates the need for researchers to engineer tissues themselves.

These Chips are produced in-house with a highly regulated process, ensuring low variability and the highest quality tissues. Researchers across biomedical research areas can contact our team to learn more about our Pre-Seeded Chips and how they can benefit their research goals. Join us in shaping the future of biomedical science with Nortis Inc